ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. ORCL
2. SPY
3. ADBE
4. RH
5. CPRT
6. ACVA
7. NVDA
8. QQQ
9. AZN
10. MU

Go back to ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.29 --0 (-0%)
Previous Close $11.29    52 Week High $2.18 
Open $11.29    52 Week Low $0.30 
Day High $11.29    P/E N/A 
Day Low $11.29    EPS $-3.32 
Volume 20,417